Last 12 months
Inside the activity.
10 purchase rows · 4 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 2 | 0 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 6 | 2 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 2 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 11, 2023 Filed Dec 19, 2023 22:57 UTC |
Finley John DavidDirector · CEO, CFO, Director
|
Exercise / conversionRestricted Stock Units · Derivative | 5,559 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001493152-23-045474 · ownership.xml · derivative · entry 3 Finley John David · CIK 0001851034 · Director · CEO, CFO, Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,583 Underlying: Common Stock · 5,559 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. F4 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. F4 · price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. F3 · derivative.exercise_date: This restricted stock unit was granted on June 11, 2023, and 5,559 restricted stock units subject to the award vested on December 11, 2023, and an additional 55,583 restricted stock units will vest in equal quarterly installments over the remaining three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting. F3 · derivative.expiration_date: This restricted stock unit was granted on June 11, 2023, and 5,559 restricted stock units subject to the award vested on December 11, 2023, and an additional 55,583 restricted stock units will vest in equal quarterly installments over the remaining three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting. Read SEC document |
| December 11, 2023 Filed Dec 19, 2023 22:57 UTC |
Finley John DavidDirector · CEO, CFO, Director
|
Exercise / conversionCommon Stock, par value $0.01 | 5,559 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-23-045474 · ownership.xml · nonDerivative · entry 1 Finley John David · CIK 0001851034 · Director · CEO, CFO, Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,340 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units. F1 · shares: Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units. F1 · price: Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units. Read SEC document |
| November 21, 2023 Filed Nov 24, 2023 16:00 UTC |
Trenschel Robert J.Director
|
GrantCommon Stock Options · Derivative | 6,880 | $0.00 Strike: $0.59 | $0.00 |
DisclosureSEC source: 0001493152-23-042665 · ownership.xml · derivative · entry 2 Trenschel Robert J. · CIK 0001849917 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,880 Underlying: Common Stock · 6,880 shares Expires 2033-11-21 F1 · security: Represents supplemental grant issued to non-employee members of Board of Directors of Issuer, which includes 5,820 restricted stock units and 6,880 common stock purchase options. The grants were issued from Issuer's 2021 Equity Incentive Plan, as amended, and were approved by the Issuer's Compensation Committee. F2 · security: The grants vest fully on the one (1) year anniversary of the grant date. F5 · security: Each option represents the right to purchase one share of common stock at the exercise price. F2 · derivative.exercise_date: The grants vest fully on the one (1) year anniversary of the grant date. Read SEC document |
| November 21, 2023 Filed Nov 24, 2023 16:00 UTC |
Trenschel Robert J.Director
|
GrantRestricted Stock Units · Derivative | 5,820 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-23-042665 · ownership.xml · derivative · entry 1 Trenschel Robert J. · CIK 0001849917 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,820 Underlying: Common Stock · 5,820 shares Expires not disclosed F1 · security: Represents supplemental grant issued to non-employee members of Board of Directors of Issuer, which includes 5,820 restricted stock units and 6,880 common stock purchase options. The grants were issued from Issuer's 2021 Equity Incentive Plan, as amended, and were approved by the Issuer's Compensation Committee. F2 · security: The grants vest fully on the one (1) year anniversary of the grant date. F3 · security: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. F2 · derivative.exercise_price: The grants vest fully on the one (1) year anniversary of the grant date. F3 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. F2 · derivative.exercise_date: The grants vest fully on the one (1) year anniversary of the grant date. F4 · derivative.expiration_date: N/A. Read SEC document |
| November 21, 2023 Filed Nov 24, 2023 21:00 UTC |
Finley John DavidDirector · CEO, CFO, Director
|
GrantCommon Stock Options · Derivative | 45,000 | $0.00 Strike: $0.59 | $0.00 |
DisclosureSEC source: 0001493152-23-042663 · ownership.xml · derivative · entry 4 Finley John David · CIK 0001851034 · Director · CEO, CFO, Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2033-11-21 F3 · security: The Grants were made as discretionary grants to Reporting Person from the Issuer's 2021 Equity Incentive Plan, as amended ("Plan"). Pursuant to Nasdaq rules, no shares may be issued pursuant to the grants until such time as there are sufficient shares of common stock available under the Plan. The applicable vesting for each grant is subject to the Reporting Person continuing to be a service provider to Issuer at the time of vesting. F7 · security: Each option represents the right to purchase one share of common stock at the exercise price. F8 · security: The grant vests in twelve (12) equal quarterly installments over a three (3) year period from the grant date. F8 · derivative.exercise_date: The grant vests in twelve (12) equal quarterly installments over a three (3) year period from the grant date. Read SEC document |
| November 21, 2023 Filed Nov 24, 2023 21:00 UTC |
Finley John DavidDirector · CEO, CFO, Director
|
GrantRestricted Stock Units · Derivative | 38,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-23-042663 · ownership.xml · derivative · entry 3 Finley John David · CIK 0001851034 · Director · CEO, CFO, Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,000 Underlying: Common Stock · 38,000 shares Expires not disclosed F3 · security: The Grants were made as discretionary grants to Reporting Person from the Issuer's 2021 Equity Incentive Plan, as amended ("Plan"). Pursuant to Nasdaq rules, no shares may be issued pursuant to the grants until such time as there are sufficient shares of common stock available under the Plan. The applicable vesting for each grant is subject to the Reporting Person continuing to be a service provider to Issuer at the time of vesting. F4 · security: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. F5 · security: The grant vests in twelve (12) equal quarterly installments over a three (3) year period with the first vesting date to occur on February 6, 2024. F5 · derivative.exercise_price: The grant vests in twelve (12) equal quarterly installments over a three (3) year period with the first vesting date to occur on February 6, 2024. F4 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. F5 · derivative.exercise_date: The grant vests in twelve (12) equal quarterly installments over a three (3) year period with the first vesting date to occur on February 6, 2024. F6 · derivative.expiration_date: N/A. Read SEC document |
| November 21, 2023 Filed Nov 24, 2023 16:00 UTC |
Diaz StephanieDirector
|
GrantCommon Stock Options · Derivative | 6,880 | $0.00 Strike: $0.59 | $0.00 |
DisclosureSEC source: 0001493152-23-042666 · ownership.xml · derivative · entry 2 Diaz Stephanie · CIK 0001850265 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,880 Underlying: Common Stock · 6,880 shares Expires 2033-11-21 F1 · security: Represents supplemental grant issued to non-employee members of Board of Directors of Issuer, which includes 5,820 restricted stock units and 6,880 common stock purchase options. The grants were issued from Issuer's 2021 Equity Incentive Plan, as amended, and were approved by the Issuer's Compensation Committee. F2 · security: The grants vest fully on the one (1) year anniversary of the grant date. F5 · security: Each option represents the right to purchase one share of common stock at the exercise price. F2 · derivative.exercise_date: The grants vest fully on the one (1) year anniversary of the grant date. Read SEC document |
| November 21, 2023 Filed Nov 24, 2023 16:00 UTC |
Diaz StephanieDirector
|
GrantRestricted Stock Units · Derivative | 5,820 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-23-042666 · ownership.xml · derivative · entry 1 Diaz Stephanie · CIK 0001850265 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,820 Underlying: Common Stock · 5,820 shares Expires not disclosed F1 · security: Represents supplemental grant issued to non-employee members of Board of Directors of Issuer, which includes 5,820 restricted stock units and 6,880 common stock purchase options. The grants were issued from Issuer's 2021 Equity Incentive Plan, as amended, and were approved by the Issuer's Compensation Committee. F2 · security: The grants vest fully on the one (1) year anniversary of the grant date. F3 · security: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. F2 · derivative.exercise_price: The grants vest fully on the one (1) year anniversary of the grant date. F3 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. F2 · derivative.exercise_date: The grants vest fully on the one (1) year anniversary of the grant date. F4 · derivative.expiration_date: N/A. Read SEC document |
| November 21, 2023 Filed Nov 24, 2023 21:00 UTC |
Williams Donald AllenDirector
|
GrantCommon Stock Options · Derivative | 6,880 | $0.00 Strike: $0.59 | $0.00 |
DisclosureSEC source: 0001493152-23-042660 · ownership.xml · derivative · entry 2 Williams Donald Allen · CIK 0001620013 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,880 Underlying: Common Stock · 6,880 shares Expires 2033-11-21 F1 · security: Represents supplemental grant issued to non-employee members of Board of Directors of Issuer, which includes 5,820 restricted stock units and 6,880 common stock purchase options. The grants were issued from Issuer's 2021 Equity Incentive Plan, as amended, and were approved by the Issuer's Compensation Committee. F2 · security: The grants vest fully on the one (1) year anniversary of the grant date. F5 · security: Each option represents the right to purchase one share of common stock at the exercise price. F2 · derivative.exercise_date: The grants vest fully on the one (1) year anniversary of the grant date. Read SEC document |
| November 21, 2023 Filed Nov 24, 2023 21:00 UTC |
Williams Donald AllenDirector
|
GrantRestricted Stock Units · Derivative | 5,820 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-23-042660 · ownership.xml · derivative · entry 1 Williams Donald Allen · CIK 0001620013 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,820 Underlying: Common Stock · 5,820 shares Expires not disclosed F1 · security: Represents supplemental grant issued to non-employee members of Board of Directors of Issuer, which includes 5,820 restricted stock units and 6,880 common stock purchase options. The grants were issued from Issuer's 2021 Equity Incentive Plan, as amended, and were approved by the Issuer's Compensation Committee. F2 · security: The grants vest fully on the one (1) year anniversary of the grant date. F3 · security: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. F2 · derivative.exercise_price: The grants vest fully on the one (1) year anniversary of the grant date. F3 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. F2 · derivative.exercise_date: The grants vest fully on the one (1) year anniversary of the grant date. F4 · derivative.expiration_date: N/A. Read SEC document |
| November 21, 2023 Filed Nov 24, 2023 21:00 UTC |
Jones Mitchell LawrenceChief Medical Officer
|
GrantCommon Stock Options · Derivative | 33,160 | $0.00 Strike: $0.59 | $0.00 |
DisclosureSEC source: 0001493152-23-042664 · ownership.xml · derivative · entry 2 Jones Mitchell Lawrence · CIK 0001993292 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,160 Underlying: Common Stock · 33,160 shares Expires 2033-11-21 F1 · security: The Grants were made as discretionary grants to Reporting Person from the Issuer's 2021 Equity Incentive Plan, as amended ("Plan"). Pursuant to Nasdaq rules, no shares may be issued pursuant to the grants until such time as there are sufficient shares of common stock available under the Plan. The applicable vesting for each grant is subject to the Reporting Person continuing to be a service provider to Issuer at the time of vesting. F5 · security: Each option represents the right to purchase one share of common stock at the exercise price. F6 · security: The grant vests in twelve (12) equal quarterly installments over a three (3) year period from the grant date. F6 · derivative.exercise_date: The grant vests in twelve (12) equal quarterly installments over a three (3) year period from the grant date. Read SEC document |
| November 21, 2023 Filed Nov 24, 2023 21:00 UTC |
Jones Mitchell LawrenceChief Medical Officer
|
GrantRestricted Stock Units · Derivative | 28,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-23-042664 · ownership.xml · derivative · entry 1 Jones Mitchell Lawrence · CIK 0001993292 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,000 Underlying: Common Stock · 28,000 shares Expires not disclosed F1 · security: The Grants were made as discretionary grants to Reporting Person from the Issuer's 2021 Equity Incentive Plan, as amended ("Plan"). Pursuant to Nasdaq rules, no shares may be issued pursuant to the grants until such time as there are sufficient shares of common stock available under the Plan. The applicable vesting for each grant is subject to the Reporting Person continuing to be a service provider to Issuer at the time of vesting. F2 · security: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. F3 · security: The grant vests in twelve (12) equal quarterly installments over a three (3) year period with the first vesting date to occur on February 6, 2024. F3 · derivative.exercise_price: The grant vests in twelve (12) equal quarterly installments over a three (3) year period with the first vesting date to occur on February 6, 2024. F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. F3 · derivative.exercise_date: The grant vests in twelve (12) equal quarterly installments over a three (3) year period with the first vesting date to occur on February 6, 2024. F4 · derivative.expiration_date: N/A. Read SEC document |
| November 21, 2023 Filed Nov 24, 2023 21:00 UTC |
Neal James RDirector
|
GrantCommon Stock Options · Derivative | 6,880 | $0.00 Strike: $0.59 | $0.00 |
DisclosureSEC source: 0001493152-23-042662 · ownership.xml · derivative · entry 2 Neal James R · CIK 0001600865 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,880 Underlying: Common Stock · 6,880 shares Expires 2033-11-21 F1 · security: Represents supplemental grant issued to non-employee members of Board of Directors of Issuer, which includes 5,820 restricted stock units and 6,880 common stock purchase options. The grants were issued from Issuer's 2021 Equity Incentive Plan, as amended, and were approved by the Issuer's Compensation Committee. F2 · security: The grants vest fully on the one (1) year anniversary of the grant date. F5 · security: Each option represents the right to purchase one share of common stock at the exercise price. F2 · derivative.exercise_date: The grants vest fully on the one (1) year anniversary of the grant date. Read SEC document |
| November 21, 2023 Filed Nov 24, 2023 21:00 UTC |
Neal James RDirector
|
GrantRestricted Stock Units · Derivative | 5,820 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-23-042662 · ownership.xml · derivative · entry 1 Neal James R · CIK 0001600865 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,820 Underlying: Common Stock · 5,820 shares Expires not disclosed F1 · security: Represents supplemental grant issued to non-employee members of Board of Directors of Issuer, which includes 5,820 restricted stock units and 6,880 common stock purchase options. The grants were issued from Issuer's 2021 Equity Incentive Plan, as amended, and were approved by the Issuer's Compensation Committee. F2 · security: The grants vest fully on the one (1) year anniversary of the grant date. F3 · security: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. F2 · derivative.exercise_price: The grants vest fully on the one (1) year anniversary of the grant date. F3 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. F2 · derivative.exercise_date: The grants vest fully on the one (1) year anniversary of the grant date. F4 · derivative.expiration_date: N/A. Read SEC document |
| November 21, 2023 Filed Nov 24, 2023 21:00 UTC |
GRAY MARY ANNDirector
|
GrantCommon Stock Options · Derivative | 6,880 | $0.00 Strike: $0.59 | $0.00 |
DisclosureSEC source: 0001493152-23-042661 · ownership.xml · derivative · entry 2 GRAY MARY ANN · CIK 0001261974 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,880 Underlying: Common Stock · 6,880 shares Expires 2033-11-21 F1 · security: Represents supplemental grant issued to non-employee members of Board of Directors of Issuer, which includes 5,820 restricted stock units and 6,880 common stock purchase options. The grants were issued from Issuer's 2021 Equity Incentive Plan, as amended, and were approved by the Issuer's Compensation Committee. F2 · security: The grants vest fully on the one (1) year anniversary of the grant date. F5 · security: Each option represents the right to purchase one share of common stock at the exercise price. F2 · derivative.exercise_date: The grants vest fully on the one (1) year anniversary of the grant date. Read SEC document |
| November 21, 2023 Filed Nov 24, 2023 21:00 UTC |
GRAY MARY ANNDirector
|
GrantRestricted Stock Units · Derivative | 5,820 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-23-042661 · ownership.xml · derivative · entry 1 GRAY MARY ANN · CIK 0001261974 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,820 Underlying: Common Stock · 5,820 shares Expires not disclosed F1 · security: Represents supplemental grant issued to non-employee members of Board of Directors of Issuer, which includes 5,820 restricted stock units and 6,880 common stock purchase options. The grants were issued from Issuer's 2021 Equity Incentive Plan, as amended, and were approved by the Issuer's Compensation Committee. F2 · security: The grants vest fully on the one (1) year anniversary of the grant date. F3 · security: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. F2 · derivative.exercise_price: The grants vest fully on the one (1) year anniversary of the grant date. F3 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. F2 · derivative.exercise_date: The grants vest fully on the one (1) year anniversary of the grant date. F4 · derivative.expiration_date: N/A. Read SEC document |
| November 21, 2023 Filed Nov 24, 2023 21:00 UTC |
Csimma CristinaDirector
|
GrantCommon Stock Options · Derivative | 6,880 | $0.00 Strike: $0.59 | $0.00 |
DisclosureSEC source: 0001493152-23-042659 · ownership.xml · derivative · entry 2 Csimma Cristina · CIK 0001501623 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,880 Underlying: Common Stock · 6,880 shares Expires 2033-11-21 F1 · security: Represents supplemental grant issued to non-employee members of Board of Directors of Issuer, which includes 5,820 restricted stock units and 6,880 common stock purchase options. The grants were issued from Issuer's 2021 Equity Incentive Plan, as amended, and were approved by the Issuer's Compensation Committee. F2 · security: The grants vest fully on the one (1) year anniversary of the grant date. F5 · security: Each option represents the right to purchase one share of common stock at the exercise price. F2 · derivative.exercise_date: The grants vest fully on the one (1) year anniversary of the grant date. Read SEC document |
| November 21, 2023 Filed Nov 24, 2023 21:00 UTC |
Csimma CristinaDirector
|
GrantRestricted Stock Units · Derivative | 5,820 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-23-042659 · ownership.xml · derivative · entry 1 Csimma Cristina · CIK 0001501623 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,820 Underlying: Common Stock · 5,820 shares Expires not disclosed F1 · security: Represents supplemental grant issued to non-employee members of Board of Directors of Issuer, which includes 5,820 restricted stock units and 6,880 common stock purchase options. The grants were issued from Issuer's 2021 Equity Incentive Plan, as amended, and were approved by the Issuer's Compensation Committee. F2 · security: The grants vest fully on the one (1) year anniversary of the grant date. F3 · security: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. F2 · derivative.exercise_price: The grants vest fully on the one (1) year anniversary of the grant date. F3 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. F2 · derivative.exercise_date: The grants vest fully on the one (1) year anniversary of the grant date. F4 · derivative.expiration_date: N/A. Read SEC document |
| November 21, 2023 Filed Nov 24, 2023 21:00 UTC |
Wei BinxianDirector
|
GrantCommon Stock Options · Derivative | 6,880 | $0.00 Strike: $0.59 | $0.00 |
DisclosureSEC source: 0001493152-23-042658 · ownership.xml · derivative · entry 2 Wei Binxian · CIK 0001773586 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,880 Underlying: Common Stock · 6,880 shares Expires 2033-11-21 F1 · security: Represents supplemental grant issued to non-employee members of Board of Directors of Issuer, which includes 5,820 restricted stock units and 6,880 common stock purchase options. The grants were issued from Issuer's 2021 Equity Incentive Plan, as amended, and were approved by the Issuer's Compensation Committee. F2 · security: The grants vest fully on the one (1) year anniversary of the grant date. F5 · security: Each option represents the right to purchase one share of common stock at the exercise price. F2 · derivative.exercise_date: The grants vest fully on the one (1) year anniversary of the grant date. Read SEC document |
| November 21, 2023 Filed Nov 24, 2023 21:00 UTC |
Wei BinxianDirector
|
GrantRestricted Stock Units · Derivative | 5,820 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-23-042658 · ownership.xml · derivative · entry 1 Wei Binxian · CIK 0001773586 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,820 Underlying: Common Stock · 5,820 shares Expires not disclosed F1 · security: Represents supplemental grant issued to non-employee members of Board of Directors of Issuer, which includes 5,820 restricted stock units and 6,880 common stock purchase options. The grants were issued from Issuer's 2021 Equity Incentive Plan, as amended, and were approved by the Issuer's Compensation Committee. F2 · security: The grants vest fully on the one (1) year anniversary of the grant date. F3 · security: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. F2 · derivative.exercise_price: The grants vest fully on the one (1) year anniversary of the grant date. F3 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. F2 · derivative.exercise_date: The grants vest fully on the one (1) year anniversary of the grant date. F4 · derivative.expiration_date: N/A. Read SEC document |
| November 20, 2023 Filed Nov 24, 2023 21:00 UTC |
Finley John DavidDirector · CEO, CFO, Director
|
GrantCommon Stock, par value $0.01 | 10,000 | $0.51 | $5,100.00 |
DisclosureSEC source: 0001493152-23-042663 · ownership.xml · nonDerivative · entry 1 Finley John David · CIK 0001851034 · Director · CEO, CFO, Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,781 F1 · security: Shares were purchased pursuant to the Palisade Bio, Inc. 2021 Employee Stock Purchase Plan, as amended ("ESPP") for the ESPP purchase period from July 1, 2023 through November 20, 2023. In accordance with the ESPP, the shares were purchased in a transaction exempt under Rule 16b-3(c) at a price equal to 85% of the closing price of the issuer's common stock on November 20, 2023. F1 · shares: Shares were purchased pursuant to the Palisade Bio, Inc. 2021 Employee Stock Purchase Plan, as amended ("ESPP") for the ESPP purchase period from July 1, 2023 through November 20, 2023. In accordance with the ESPP, the shares were purchased in a transaction exempt under Rule 16b-3(c) at a price equal to 85% of the closing price of the issuer's common stock on November 20, 2023. F1 · price: Shares were purchased pursuant to the Palisade Bio, Inc. 2021 Employee Stock Purchase Plan, as amended ("ESPP") for the ESPP purchase period from July 1, 2023 through November 20, 2023. In accordance with the ESPP, the shares were purchased in a transaction exempt under Rule 16b-3(c) at a price equal to 85% of the closing price of the issuer's common stock on November 20, 2023. Read SEC document |
| November 07, 2023 Filed Nov 8, 2023 22:01 UTC |
Jones Mitchell LawrenceChief Medical Officer
|
Tax withholdingCommon Stock, par value $0.01 | 1,630 | $0.54 | $878.41 |
DisclosureSEC source: 0001493152-23-039935 · ownership.xml · nonDerivative · entry 2 Jones Mitchell Lawrence · CIK 0001993292 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,926 F2 · security: Represents shares sold on behalf of Reporting Person to satisfy tax requirements related to the vesting of the restricted stock units. F2 · price: Represents shares sold on behalf of Reporting Person to satisfy tax requirements related to the vesting of the restricted stock units. Read SEC document |
| November 06, 2023 Filed Nov 8, 2023 22:01 UTC |
Finley John DavidDirector · CEO, CFO, Director
|
Exercise / conversionRestricted Stock Units · Derivative | 3,475 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001493152-23-039936 · ownership.xml · derivative · entry 3 Finley John David · CIK 0001851034 · Director · CEO, CFO, Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,275 Underlying: Common Stock · 3,475 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. F4 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. F4 · price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. F3 · derivative.exercise_date: This restricted stock unit was granted on February 6, 2023, and 3,475 restricted stock units subject to the award vested on November 6, 2023, and an additional 31,275 restricted stock units will vest in equal installments over the remaining three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting. F3 · derivative.expiration_date: This restricted stock unit was granted on February 6, 2023, and 3,475 restricted stock units subject to the award vested on November 6, 2023, and an additional 31,275 restricted stock units will vest in equal installments over the remaining three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting. Read SEC document |
| November 06, 2023 Filed Nov 8, 2023 22:01 UTC |
Finley John DavidDirector · CEO, CFO, Director
|
Exercise / conversionCommon Stock, par value $0.01 | 3,475 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-23-039936 · ownership.xml · nonDerivative · entry 1 Finley John David · CIK 0001851034 · Director · CEO, CFO, Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,781 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units. F1 · shares: Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units. F1 · price: Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units. Read SEC document |
| November 06, 2023 Filed Nov 8, 2023 22:01 UTC |
Jones Mitchell LawrenceChief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 4,556 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001493152-23-039935 · ownership.xml · derivative · entry 3 Jones Mitchell Lawrence · CIK 0001993292 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,144 Underlying: Common Stock · 4,556 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. F4 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. F4 · price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. F3 · derivative.exercise_date: This restricted stock unit was granted on September 5, 2023, and 4,556 restricted stock units subject to the award vested on November 6, 2023, and an additional 50,144 restricted stock units will vest in equal installments over the eleven (11) quarterly periods thereafter, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting. F3 · derivative.expiration_date: This restricted stock unit was granted on September 5, 2023, and 4,556 restricted stock units subject to the award vested on November 6, 2023, and an additional 50,144 restricted stock units will vest in equal installments over the eleven (11) quarterly periods thereafter, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting. Read SEC document |
| November 06, 2023 Filed Nov 8, 2023 22:01 UTC |
Jones Mitchell LawrenceChief Medical Officer
|
Exercise / conversionCommon Stock, par value $0.01 | 4,556 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-23-039935 · ownership.xml · nonDerivative · entry 1 Jones Mitchell Lawrence · CIK 0001993292 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,556 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units. F1 · shares: Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units. F1 · price: Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units. Read SEC document |
| October 04, 2023 Filed Oct 5, 2023 21:46 UTC |
Finley John DavidDirector · CEO, CFO, Director
|
Tax withholdingCommon Stock, par value $0.01 | 397 | $0.55 | $218.39 |
DisclosureSEC source: 0001493152-23-036404 · ownership.xml · nonDerivative · entry 2 Finley John David · CIK 0001851034 · Director · CEO, CFO, Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,306 F2 · security: Represents shares sold on behalf of Reporting Person to satisfy tax requirements related to the vesting of the restricted stock units. F2 · price: Represents shares sold on behalf of Reporting Person to satisfy tax requirements related to the vesting of the restricted stock units. Read SEC document |
| October 03, 2023 Filed Oct 5, 2023 21:46 UTC |
Finley John DavidDirector · CEO, CFO, Director
|
Exercise / conversionRestricted Stock Units · Derivative | 1,309 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001493152-23-036404 · ownership.xml · derivative · entry 4 Finley John David · CIK 0001851034 · Director · CEO, CFO, Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,309 Underlying: Common Stock · 1,309 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. F1 · price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. F4 · derivative.exercise_date: This restricted stock unit was granted on January 3, 2023, and 1,309 restricted stock units subject to the award vested on October 4, 2023, and an additional 1,309 restricted stock units will vest on January 3, 2024, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting. F4 · derivative.expiration_date: This restricted stock unit was granted on January 3, 2023, and 1,309 restricted stock units subject to the award vested on October 4, 2023, and an additional 1,309 restricted stock units will vest on January 3, 2024, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting. Read SEC document |
| October 03, 2023 Filed Oct 5, 2023 21:46 UTC |
Finley John DavidDirector · CEO, CFO, Director
|
Exercise / conversionCommon Stock, par value $0.01 | 1,309 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-23-036404 · ownership.xml · nonDerivative · entry 1 Finley John David · CIK 0001851034 · Director · CEO, CFO, Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,703 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. F1 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. F1 · price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. Read SEC document |
| September 27, 2023 Filed Sep 29, 2023 13:21 UTC |
Finley John DavidDirector · CEO, CFO, Director
|
PurchaseCommon Stock, par value $0.01 | 15,000 | $0.54 | $8,088.00 |
DisclosureSEC source: 0001493152-23-034754 · ownership.xml · nonDerivative · entry 1 Finley John David · CIK 0001851034 · Director · CEO, CFO, Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,394 F1 · shares: Reporting Person purchased 15,000 shares of Common Stock of Issuer at a price per share of $0.5392 on September 27, 2023. F1 · price: Reporting Person purchased 15,000 shares of Common Stock of Issuer at a price per share of $0.5392 on September 27, 2023. Read SEC document |
| September 27, 2023 Filed Sep 29, 2023 13:25 UTC |
Williams Donald AllenDirector
|
PurchaseCommon Stock, par value $0.01 | 20,000 | $0.54 | $10,800.00 |
DisclosureSEC source: 0001493152-23-034756 · ownership.xml · nonDerivative · entry 1 Williams Donald Allen · CIK 0001620013 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Reporting Person's Defined Benefit Plan Disclosed balance after: 20,000 F1 · shares: Reporting Person purchased 20,000 shares of Common Stock of Issuer at a price per share of $0.54 on September 27, 2023. F1 · price: Reporting Person purchased 20,000 shares of Common Stock of Issuer at a price per share of $0.54 on September 27, 2023. Read SEC document |
| September 14, 2023 Filed Sep 15, 2023 17:15 UTC |
Trenschel Robert J.Director
|
SaleCommon Stock, par value $0.01 | 300 | $0.64 | $192.00 |
DisclosureSEC source: 0001493152-23-032794 · ownership.xml · nonDerivative · entry 1 Trenschel Robert J. · CIK 0001849917 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · shares: Reflects the weighted average sale price. The range of prices for such transaction was $0.6396 to $0.6507. Open market sale transactions were made on the same day at different prices through a trade order executed by a broker-dealer. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. F1 · price: Reflects the weighted average sale price. The range of prices for such transaction was $0.6396 to $0.6507. Open market sale transactions were made on the same day at different prices through a trade order executed by a broker-dealer. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 13, 2023 Filed Sep 14, 2023 21:00 UTC |
Finley John DavidDirector · CEO, CFO, Director
|
PurchaseCommon Stock, par value $0.01 | 15,000 | $0.66 | $9,825.00 |
DisclosureSEC source: 0001493152-23-032655 · ownership.xml · nonDerivative · entry 1 Finley John David · CIK 0001851034 · Director · CEO, CFO, Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,394 F1 · shares: Reporting Person purchased 15,000 shares of Common Stock at prices ranging from $0.636 to $0.658 with a weighted average price per share of $0.655 on September 13, 2023. The Reporting Person agrees to provide full information regarding the number of shares purchased at each separate price paid if requested by the SEC staff, the Issuer, or a security holder of the Issuer. F1 · price: Reporting Person purchased 15,000 shares of Common Stock at prices ranging from $0.636 to $0.658 with a weighted average price per share of $0.655 on September 13, 2023. The Reporting Person agrees to provide full information regarding the number of shares purchased at each separate price paid if requested by the SEC staff, the Issuer, or a security holder of the Issuer. Read SEC document |
| September 12, 2023 Filed Sep 13, 2023 20:55 UTC |
Finley John DavidDirector · CEO, CFO, Director
|
Tax withholdingCommon Stock, par value $0.01 | 1,792 | $0.66 | $1,173.76 |
DisclosureSEC source: 0001493152-23-032505 · ownership.xml · nonDerivative · entry 2 Finley John David · CIK 0001851034 · Director · CEO, CFO, Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,394 F2 · security: Represents shares sold on behalf of Reporting Person on September 11, 2023, to satisfy tax requirements related to the vesting of the restricted stock units. F2 · price: Represents shares sold on behalf of Reporting Person on September 11, 2023, to satisfy tax requirements related to the vesting of the restricted stock units. Read SEC document |
| September 11, 2023 Filed Sep 13, 2023 20:55 UTC |
Finley John DavidDirector · CEO, CFO, Director
|
Exercise / conversionRestricted Stock Units · Derivative | 5,558 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001493152-23-032505 · ownership.xml · derivative · entry 4 Finley John David · CIK 0001851034 · Director · CEO, CFO, Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,142 Underlying: Common Stock · 5,558 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. F1 · price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. F4 · derivative.exercise_date: This restricted stock unit was granted on June 11, 2023, and 5,558 restricted stock units subject to the award vested on September 11, 2023, and an additional 61,142 restricted stock units will vest in equal installments over the remaining three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting. F4 · derivative.expiration_date: This restricted stock unit was granted on June 11, 2023, and 5,558 restricted stock units subject to the award vested on September 11, 2023, and an additional 61,142 restricted stock units will vest in equal installments over the remaining three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting. Read SEC document |
| September 11, 2023 Filed Sep 13, 2023 20:55 UTC |
Finley John DavidDirector · CEO, CFO, Director
|
Exercise / conversionCommon Stock, par value $0.01 | 5,558 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-23-032505 · ownership.xml · nonDerivative · entry 1 Finley John David · CIK 0001851034 · Director · CEO, CFO, Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,186 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. F1 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. F1 · price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. Read SEC document |
| August 11, 2023 Filed Aug 14, 2023 22:33 UTC |
Finley John DavidDirector · CEO, CFO, Director
|
Tax withholdingCommon Stock, par value $0.01 | 1,040 | $0.70 | $728.00 |
DisclosureSEC source: 0001493152-23-028702 · ownership.xml · nonDerivative · entry 2 Finley John David · CIK 0001851034 · Director · CEO, CFO, Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,628 F2 · security: Represents shares sold on behalf of Reporting Person on August 11, 2023, to satisfy tax requirements related to the vesting of the restricted stock units. F2 · price: Represents shares sold on behalf of Reporting Person on August 11, 2023, to satisfy tax requirements related to the vesting of the restricted stock units. Read SEC document |
| August 06, 2023 Filed Aug 14, 2023 22:33 UTC |
Finley John DavidDirector · CEO, CFO, Director
|
Exercise / conversionRestricted Stock Units · Derivative | 3,475 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001493152-23-028702 · ownership.xml · derivative · entry 4 Finley John David · CIK 0001851034 · Director · CEO, CFO, Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,750 Underlying: Common Stock · 3,475 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. F1 · price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. F4 · derivative.exercise_date: This restricted stock unit was granted on February 6, 2023, and 3,475 restricted stock units subject to the award vested on August 6, 2023, and an additional 34,750 restricted stock units will vest in equal installments over the remaining three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting. F4 · derivative.expiration_date: This restricted stock unit was granted on February 6, 2023, and 3,475 restricted stock units subject to the award vested on August 6, 2023, and an additional 34,750 restricted stock units will vest in equal installments over the remaining three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting. Read SEC document |
| August 06, 2023 Filed Aug 14, 2023 22:33 UTC |
Finley John DavidDirector · CEO, CFO, Director
|
Exercise / conversionCommon Stock, par value $0.01 | 3,475 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-23-028702 · ownership.xml · nonDerivative · entry 1 Finley John David · CIK 0001851034 · Director · CEO, CFO, Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,057 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. F1 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. F1 · price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. Read SEC document |
| July 06, 2023 Filed Jul 6, 2023 22:27 UTC |
Finley John DavidDirector · CEO, CFO, Director
|
Tax withholdingCommon Stock, par value $0.01 | 389 | $1.76 | $686.20 |
DisclosureSEC source: 0001493152-23-023867 · ownership.xml · nonDerivative · entry 2 Finley John David · CIK 0001851034 · Director · CEO, CFO, Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,193 F2 · security: Represents shares sold on behalf of Reporting Person to satisfy tax requirements related to the vesting of the restricted stock units. F2 · price: Represents shares sold on behalf of Reporting Person to satisfy tax requirements related to the vesting of the restricted stock units. Read SEC document |
| July 03, 2023 Filed Jul 6, 2023 22:27 UTC |
Finley John DavidDirector · CEO, CFO, Director
|
Exercise / conversionRestricted Stock Units · Derivative | 1,309 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001493152-23-023867 · ownership.xml · derivative · entry 4 Finley John David · CIK 0001851034 · Director · CEO, CFO, Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,618 Underlying: Common Stock · 1,309 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. F1 · price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. F4 · derivative.exercise_date: This restricted stock unit was granted on January 3, 2023, and 1,309 restricted stock units subject to the award vested on July 3, 2023, and an additional 1,309 restricted stock units will vest on each of October 3, 2023 and January 3, 2024, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting. F4 · derivative.expiration_date: This restricted stock unit was granted on January 3, 2023, and 1,309 restricted stock units subject to the award vested on July 3, 2023, and an additional 1,309 restricted stock units will vest on each of October 3, 2023 and January 3, 2024, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting. Read SEC document |
| July 03, 2023 Filed Jul 6, 2023 22:27 UTC |
Finley John DavidDirector · CEO, CFO, Director
|
Exercise / conversionCommon Stock, par value $0.01 | 1,309 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-23-023867 · ownership.xml · nonDerivative · entry 1 Finley John David · CIK 0001851034 · Director · CEO, CFO, Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,582 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. F1 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. F1 · price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. Read SEC document |
| June 13, 2023 Filed Jun 14, 2023 22:23 UTC |
Finley John DavidDirector · CEO, CFO, Director
|
Tax withholdingCommon Stock, par value $0.01 | 1,050 | $1.54 | $1,618.58 |
DisclosureSEC source: 0001493152-23-021308 · ownership.xml · nonDerivative · entry 2 Finley John David · CIK 0001851034 · Director · CEO, CFO, Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,273 F2 · security: Represents shares sold on behalf of Reporting Person to satisfy tax requirements related to the vesting of the restricted stock units. F2 · price: Represents shares sold on behalf of Reporting Person to satisfy tax requirements related to the vesting of the restricted stock units. Read SEC document |
| June 12, 2023 Filed Jun 14, 2023 22:23 UTC |
Finley John DavidDirector · CEO, CFO, Director
|
Exercise / conversionRestricted Stock Units · Derivative | 3,475 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001493152-23-021308 · ownership.xml · derivative · entry 4 Finley John David · CIK 0001851034 · Director · CEO, CFO, Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,225 Underlying: Common Stock · 3,475 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. F1 · price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. F4 · derivative.exercise_date: This restricted stock unit was granted on February 6, 2023, and 3,475 restricted stock units subject to the award vested on June 12, 2023, upon receipt of shareholder approval of the grant, and an additional 38,225 restricted stock units will vest in equal installments over the remaining three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting. F4 · derivative.expiration_date: This restricted stock unit was granted on February 6, 2023, and 3,475 restricted stock units subject to the award vested on June 12, 2023, upon receipt of shareholder approval of the grant, and an additional 38,225 restricted stock units will vest in equal installments over the remaining three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting. Read SEC document |
| June 12, 2023 Filed Jun 14, 2023 22:23 UTC |
Finley John DavidDirector · CEO, CFO, Director
|
Exercise / conversionCommon Stock, par value $0.01 | 3,475 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-23-021308 · ownership.xml · nonDerivative · entry 1 Finley John David · CIK 0001851034 · Director · CEO, CFO, Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,323 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. F1 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. F1 · price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. Read SEC document |
| June 11, 2023 Filed Jun 13, 2023 18:44 UTC |
Trenschel Robert J.Director
|
GrantCommon Stock Options · Derivative | 12,160 | $0.00 Strike: $1.60 | $0.00 |
DisclosureSEC source: 0001493152-23-021133 · ownership.xml · derivative · entry 2 Trenschel Robert J. · CIK 0001849917 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,160 Underlying: Common Stock · 12,160 shares Expires 2033-06-11 F1 · security: Represents partial compensation for services as a director pursuant to Issuer's director compensation policy, which includes 5,100 restricted stock units and 7,000 common stock purchase options. The grants were issued from Issuer's 2021 Equity Incentive Plan. In addition, Reporting Person received, per its election, an additional 5,160 common stock purchase options as a discretionary grant. F2 · security: The grants vest fully on the one (1) year anniversary of the grant date. F5 · security: Each option represents the right to purchase one share of common stock at the exercise price. F2 · derivative.exercise_date: The grants vest fully on the one (1) year anniversary of the grant date. Read SEC document |
| June 11, 2023 Filed Jun 13, 2023 18:44 UTC |
Trenschel Robert J.Director
|
GrantRestricted Stock Units · Derivative | 5,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-23-021133 · ownership.xml · derivative · entry 1 Trenschel Robert J. · CIK 0001849917 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,100 Underlying: Common Stock · 5,100 shares Expires not disclosed F1 · security: Represents partial compensation for services as a director pursuant to Issuer's director compensation policy, which includes 5,100 restricted stock units and 7,000 common stock purchase options. The grants were issued from Issuer's 2021 Equity Incentive Plan. In addition, Reporting Person received, per its election, an additional 5,160 common stock purchase options as a discretionary grant. F3 · security: Each restricted stock unit represents the right to receive one share of common stock. F2 · derivative.exercise_price: The grants vest fully on the one (1) year anniversary of the grant date. F3 · shares: Each restricted stock unit represents the right to receive one share of common stock. F2 · derivative.exercise_date: The grants vest fully on the one (1) year anniversary of the grant date. F4 · derivative.expiration_date: N/A Read SEC document |
| June 11, 2023 Filed Jun 13, 2023 22:43 UTC |
Finley John DavidDirector · CEO, CFO, Director
|
GrantCommon Stock Options · Derivative | 148,500 | $0.00 Strike: $1.60 | $0.00 |
DisclosureSEC source: 0001493152-23-021131 · ownership.xml · derivative · entry 2 Finley John David · CIK 0001851034 · Director · CEO, CFO, Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 148,500 Underlying: Common Stock · 148,500 shares Expires 2033-06-11 F1 · security: The Grants were made as discretionary grants to the Reporting Person, from the Issuer's 2021 Equity Incentive Plan, as amended. Each grant vests in twelve (12) equal quarterly installments over a three (3) year period from the grant date, subject to Reporting Person continuing to be a service provider at the time of vesting. F3 · security: Each option represents the right to purchase one share of common stock at the exercise price. F1 · derivative.exercise_date: The Grants were made as discretionary grants to the Reporting Person, from the Issuer's 2021 Equity Incentive Plan, as amended. Each grant vests in twelve (12) equal quarterly installments over a three (3) year period from the grant date, subject to Reporting Person continuing to be a service provider at the time of vesting. Read SEC document |
| June 11, 2023 Filed Jun 13, 2023 22:43 UTC |
Finley John DavidDirector · CEO, CFO, Director
|
GrantRestricted Stock Units · Derivative | 66,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-23-021131 · ownership.xml · derivative · entry 1 Finley John David · CIK 0001851034 · Director · CEO, CFO, Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,700 Underlying: Common Stock · 66,700 shares Expires not disclosed F1 · security: The Grants were made as discretionary grants to the Reporting Person, from the Issuer's 2021 Equity Incentive Plan, as amended. Each grant vests in twelve (12) equal quarterly installments over a three (3) year period from the grant date, subject to Reporting Person continuing to be a service provider at the time of vesting. F2 · security: Each restricted stock unit represents the right to receive one share of common stock. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of common stock. F2 · shares: Each restricted stock unit represents the right to receive one share of common stock. F1 · derivative.exercise_date: The Grants were made as discretionary grants to the Reporting Person, from the Issuer's 2021 Equity Incentive Plan, as amended. Each grant vests in twelve (12) equal quarterly installments over a three (3) year period from the grant date, subject to Reporting Person continuing to be a service provider at the time of vesting. F4 · derivative.expiration_date: N/A Read SEC document |
| June 11, 2023 Filed Jun 13, 2023 18:44 UTC |
Diaz StephanieDirector
|
GrantCommon Stock Options · Derivative | 9,580 | $0.00 Strike: $1.60 | $0.00 |
DisclosureSEC source: 0001493152-23-021126 · ownership.xml · derivative · entry 2 Diaz Stephanie · CIK 0001850265 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,580 Underlying: Common Stock · 9,580 shares Expires 2033-06-11 F1 · security: Represents partial compensation for services rendered as a director pursuant to Issuer's director compensation policy, which includes 5,100 restricted stock units and 7,000 common stock purchase options. The grants were issued from the Issuer's 2021 Equity Incentive Plan. In addition, Reporting Person received, per its election, an additional 1,880 restricted stock units and 2,580 common stock purchase options as a discretionary grant. F2 · security: The grants vest fully on the one (1) year anniversary of the grant date. F5 · security: Each option represents the right to purchase one share of common stock at the exercise price. F2 · derivative.exercise_date: The grants vest fully on the one (1) year anniversary of the grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.